OCTOPUS Industry Engagement Day!
The world’s first adaptive clinical trial platform in progressive MS evaluating multiple treatments using a multi-arm, multi-stage (MAMS) design.
OCTOPUS are looking for new partnerships as OCTOPUS has the infrastructure and innovative design, to rapidly assess existing and new treatments that could slow down, or ultimately stop, the progression of disability in people with MS.
Adding treatments to an existing trial platform provides significant reduction in set up time as well as increased efficiency.
This is because OCTOPUS has:
-
Established governance and management structures.
-
A registration of interest portal with >2000 potential participants.
-
UK sites open and recruiting with full MRI capacity.
- 88% of participants screened proceeding to randomisation.
Would your company be interested in working with OCTOPUS?
If so, OCTOPUS would like to invite you to the OCTOPUS Industry Engagement Day!
This will be held on Monday 30th January 2025 between 10.00 – 15.00 GMT (with refreshments and lunch provided) at MRC CTU at UCL, 2nd floor, 90 High Holborn, London WC1V 6LJ.
At this meeting you will hear the latest progress and future plans from the OCTOPUS team and if desired opportunity for separate discussions on individual collaborations.
If you would like to attend, please email mrcctu.octopus@ucl.ac.uk with your name, position, and company name.
We hope that you will be able to join us.
Best wishes
